NERDBOT
    Facebook Twitter Instagram YouTube
    Subscribe
    NERDBOT
    • News
      • Reviews
    • Movies & TV
    • Comics
    • Gaming
    • Collectibles
    • Science & Tech
    • Nerd Culture
    • About Us
      • Want to Write for Nerdbot?
    NERDBOT
    Home»News»FDA Approves First New Alzheimer’s Drug in 20 Years
    Photo by Andrea Piacquadio from Pexels
    News

    FDA Approves First New Alzheimer’s Drug in 20 Years

    Breana CeballosBy Breana CeballosJune 7, 2021Updated:June 7, 20213 Mins Read
    Share
    Facebook Twitter Pinterest Reddit WhatsApp Email

    Aducanumab is going to be the thing most everyone is talking about. It’s a new drug that has been approved by the Food and Drug Administration to treat early signs of Alzheimer’s. The problem with it however that it was approved despite there being evidence that the pros outweigh the cons. And the FDA advisory committee said that it also lacked evidence that it would be effective in treating the disease at all. The reason that’s its noteworthy that this drug was approved is because the FDA has not approved a new drug for treatment in over 20 years.

    This new drug, aducanumab, was created to treat the early symptoms and ease progression of Alzheimer’s. It’s not for people with advanced Alzheimer’s or dementia.

    In response to a question about whether it was reasonable to consider data from one positive study as the primary evidence of aducanumab’s effectiveness for the treatment of early Alzheimer’s disease, none of the committee members voted yes — 10 voted no and one was uncertain.

    ABC7 News

    Administered intravenously, the drug was created by pharmaceutical company Biogen, and its Japanese partner, Eisai. Dr. Richard Isaacson, director of the Alzheimer’s Prevention Clinic at Weill Cornell Medicine and NewYork-Presbyterian in New York was part of the initial study. He had patients try the new drug and says that “we really have to temper our expectations.”

    “This drug targets the earliest symptomatic phase of the disease, called mild cognitive impairment due to Alzheimer’s. Treatment of this pre-dementia period is what the FDA is deciding on”

    “We have to really temper expectations and explain to people that this drug is meant for the earliest symptomatic phases. It pains me to say this but if I have a severe Alzheimer’s patient that can no longer speak or interact much with others and their family member is begging me to give them this drug, I won’t be able to do it.”

    Dr. Richard Isaacson
    Photo by Andrea Piacquadio from Pexels

    It’s Expensive and It Might Not Work

    Along with not enough evidence to support that it’s more helpful than harmful there is also a large price tag to even try this out. In May, the Institute for Clinical and Economic Review put out a draft report guessing that the drug should cost between $2,560 to $8,290 per year. That’s a lot of money for something that might not work.

    It wasn’t until a study run by Biogen, one of the companies that manufactures the drug was put out. With the numbers released from the new study it was found that with a very high dose of the drug it stalled the progression of Alzheimer’s.

    The company noted in FDA briefing documents last year that patients treated with high-dose aducanumab showed 22% less clinical decline in their cognitive health at about 18 months — meaning the progression of their early Alzheimer’s disease slowed — compared with those who received a placebo

    ABC7

    Author

    • Breana Ceballos
    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email
    Previous ArticleBrood X is on the Move: Cicada Swarm Ping Weather Systems
    Next Article Rap Snacks: Chips and Ramen Celebrating Rap Icons [Food Review]
    Breana Ceballos
    • Website
    • Facebook
    • Twitter

    Hi! I am the Managing Editor for Nerdbot.com I enjoy watching anime, learning about new things and keeping up with Nerd Culture. I love writing and hope to introduce people to things that they may not have known about before through my articles. If you think you may be interested in submitting a guest article please check out the "Write for Nerdbot" section on the main page!

    Related Posts

    Back to School Lunch Ruined: Capri Sun Wild Cherry Recalled

    August 15, 2022

    Mike the Headless Chicken Still Celebrated with Annual Festival

    August 15, 2022

    “Day Shift” is Fun, Over-the-Top Vampire Romp [Review]

    August 15, 2022

    LEGO Ideas: “Yu-Gi-Oh!” Favorites that Hold Your Cards!

    August 14, 2022

    “Bodies Bodies Bodies”- Good Good Good from A24 [Review]

    August 13, 2022

    SvahaUSA, STEAM Team Up for Galaxy Fashion Clothing

    August 13, 2022
    Subscribe for the Latest News
    • Trending
    • Latest
    • Movies
    • TV

    Christian Activist Suing The NFL For $867 Trillion Over Half-Time Show

    February 5, 2020

    Marvel Eyeing GOT Star Nathalie Emmanuel To Play The MCU’s Storm

    June 27, 2019

    Rumor: Charlie Hunnam In Talks For New Wolverine Movie

    May 20, 2019

    Scientists Are Actually Trying to Open a Portal to a Mirror Universe(Yes Really)

    December 28, 2019

    Back to School Lunch Ruined: Capri Sun Wild Cherry Recalled

    August 15, 2022

    Mike the Headless Chicken Still Celebrated with Annual Festival

    August 15, 2022

    Convenient Cricket Betting in the Dafabet App

    August 15, 2022

    Yet Another “Saw” Franchise Entry Coming Next Year

    August 15, 2022

    Yet Another “Saw” Franchise Entry Coming Next Year

    August 15, 2022

    “Day Shift” is Fun, Over-the-Top Vampire Romp [Review]

    August 15, 2022

    Sasheen Littlefeather Gets Academy Apology After Nearly 50 Years

    August 15, 2022

    It’s John Carpenter’s “The Thing,” But with Pingu

    August 15, 2022

    Peacock Nabs “John Wick” Prequel “The Continental” from STARZ

    August 15, 2022

    Guillermo del Toro’s “Cabinet of Curiosities” Gets First Look, Release Date!

    August 15, 2022

    Lauren Ambrose Joins “Yellowjackets” for Season 2

    August 12, 2022

    Netflix Renews “Love, Death + Robots” for Volume IV!

    August 12, 2022
    Related Posts

    None found

    San Diego Comic-Con
      • auction
      • carnivorous plant
      • dinosaur
      • pennyworth
      • San Diego Comic-Con
    NERDBOT
    Facebook Twitter Instagram YouTube
    © 2022 NERDBOT Media

    Type above and press Enter to search. Press Esc to cancel.